Eyegate pharmaceuticals inc (EYEG)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Collaboration Revenue

0

-

0

-

2,686

-

314

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration Revenue

-

-

-

0

-

-

-

242

1,096

-

74

148

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration Revenue

-

-

-

-

-

-

-

-

-

-

-

-

184

160

274

234

0

-

0

0

-

-

-

-

-

Operating Expenses:
Research and Development

938

1,497

2,406

763

721

1,437

2,259

1,837

2,521

3,077

3,175

2,262

1,815

2,577

2,449

2,481

913

1,383

407

604

321

109

111

92

217

General and Administrative

1,032

1,118

1,045

1,105

1,135

1,052

1,232

1,202

954

1,095

1,038

1,212

1,289

1,283

1,201

1,579

1,528

1,291

946

939

782

284

480

510

656

Total Operating Expenses

1,970

2,616

3,451

1,869

1,857

2,489

3,492

3,040

3,475

4,172

4,214

3,475

3,104

3,861

3,651

4,060

2,442

2,675

1,353

1,543

1,104

393

592

602

874

Operating (Loss) Income Before Other Income, Net

-1,970

-

-3,451

-1,869

828

-

-3,177

-2,798

-2,379

-

-4,140

-3,326

-2,919

-

-3,376

-3,826

-

-

-

-

-

-

-

-

-

Other Income, Net:
Research & development tax credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-9

22

2

Interest Income

18

10

22

32

42

47

54

18

0

0

0

0

0

0

0

2

0

-1

0

2

0

0

0

0

0

Extinguishment of research liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

240

-

-

Change in Fair Value of Warrant Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-223

-218

-881

5

0

Interest Expense

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

14

0

0

1,920

177

169

62

32

Other Income, Net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-1

0

0

0

0

0

0

Total Other Income, Net

18

10

22

32

42

47

54

18

-0

-0

-0

-0

-0

-0

0

2

0

-14

-1

2

-1,696

41

942

-44

-28

Net (Loss) Income

-1,952

-2,701

-3,428

-1,837

870

-2,528

-3,123

-2,780

-2,379

-2,831

-4,140

-3,326

-2,919

-

-

-

-

-

-

-

-

-

-

-

-

Net (Loss) Income Per Common Share - Basic

-0.43

-

-

-

0.30

-

-

-

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (Loss) Income Per Common Share - Diluted

-0.43

-

-

-

0.19

-

-

-

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-Average Shares Outstanding- Basic

4,524

-

-

-

2,917

-

-

-

17,257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-Average Shares Outstanding - Diluted

4,524

-

-

-

4,495

-

-

-

17,257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,701

-3,376

-3,823

-2,442

-2,689

-1,355

-1,541

-2,801

-351

350

-646

-902

Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,541

-2,801

-

350

-646

-902

Deemed Dividend on Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

8,222

-

0

0

0

Net Loss per Common Share - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

0

0

-5

64

40

58

58

Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,689

-1,355

-1,541

-11,028

-416

309

-705

-961

Net Loss per Common Share- Basic and Diluted

-

-

-1.15

-0.04

-

-

-1.08

-0.07

-

-0.13

-0.24

-0.28

-0.28

-

-0.36

-0.46

-0.31

0.96

-0.19

-0.24

-3.23

-6.50

1.59

-3.82

-0.47

Weighted Average Shares Outstanding- Basic and Diluted

-

-

2,982

43,800

-

-

2,879

37,484

-

17,312

17,204

12,067

10,456

9,844

9,269

8,374

7,846

7,713

7,161

6,363

3,417

-1,633

194

184

2,025

Net (Loss) Income

-1,952

-2,701

-3,428

-1,837

870

-

-3,123

-2,780

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,701

-3,376

-3,823

-2,442

-2,689

-1,355

-1,541

-2,801

-351

350

-646

-902

Other Comprehensive (Loss) Income:
Foreign Currency Translation Adjustments

0

1

2

1

-0

-2

6

2

1

1

3

2

0

5

0

-0

-0

16

-6

29

51

-

-2

-14

8

Comprehensive (Loss) Income

-1,952

-2,700

-3,425

-1,835

870

-2,530

-3,117

-2,778

-2,378

-2,829

-4,137

-3,324

-2,919

-3,695

-3,375

-3,823

-2,442

-

-1,362

-1,511

-

-

347

-661

-911

Net Loss Attributable to Non-Controlling Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

0

0

-5

64

40

58

58

Other Comprehensive Income Attributable to Non-Controlling Interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-65

0

0

32

-

-86

24

6

Comprehensive Income Attributable to Non-Controlling Interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-55

0

0

27

-

-46

82

65

Comprehensive Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,673

-1,362

-1,511

-2,721

-

393

-743

-959